Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 15, 2025 08:01 ET | Source: Kaléo

Retrospective Analysis of U.S. Claims Data Shows AUVI-Q® (epinephrine injection, USP) Prescription Associated with Lower Rates of Anaphylaxis-Related Inpatient Hospitalizations Compared to Other Epinephrine Auto-Injectors

Richmond, Virginia, May 15, 2025 (GLOBE NEWSWIRE) -- New findings from a retrospective analysis of U.S. commercial claims data indicate that patients prescribed AUVI-Q® (epinephrine injection, USP)...
September 21, 2022 08:00 ET | Source: Kaléo

Kaléo Announces First U.S. Department of Defense Supply Contract for the Rapid Opioid Countermeasure System (ROCS) Antidote for Ultra-Potent Weaponized Opioids

Richmond, VA, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Kaléo, a privately held commercial-stage U.S. pharmaceutical company, today announced the execution of the first contract with the U.S. Department of...
August 11, 2022 08:25 ET | Source: Kaléo

Kaléo Announces Executive Appointments and New Government Business Unit

Richmond, VA, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Kaléo, a fully integrated pharmaceutical company dedicated to inventing, manufacturing, and commercializing life-transforming products for certain...
August 03, 2017 12:00 ET | Source: Minor League Baseball

Minor League Baseball, AUVI-Q® (Epinephrine Injection, USP) Team Up to Keep Fans with Peanut Allergies in the Game

ST. PETERSBURG, Fla. and RICHMOND, Va., Aug. 03, 2017 (GLOBE NEWSWIRE) -- It’s hard to imagine a baseball game without peanuts, but in a new collaboration between Minor League Baseball® (MiLB™) and...